Spasticity and Treatment Satisfaction Among Stroke Survivors

Perceived Spasticity and Treatment Satisfaction Among Stroke Survivors Over the Course of a Complete Treatment Cycle With Botulinum Neurotoxin A (BoNT-A): an Ethnographic Study.

To investigate, through ethnography, changes in symptom burden and disability and their effects/interference on patient functioning, ability to perform activities of daily living (ADL) and quality of life (QoL) throughout the duration of one BoNT-A treatment cycle.

Inclusion Criteria:

• Diagnostic of post-stroke spasticity more than three months prior to inclusion
• At least 6 months on treatment (or two treatment cycles) with BoNT-A injections for spasticity according to the decision of the physician
• Previous BoNT-A injection cycles did not last for more than 16 weeks
• Ambulatory (use of walking aids is acceptable)

Exclusion Criteria:

• Neurological disorder other than stroke
• Spasticity-specific treatment changes within 3 months prior to inclusion
• Patients who had undergone neurolysis or surgery to the affected limb within 6 months
• Concurrent participation in a clinical trial for the treatment of spasticity